Use of calcium channel blockers in cardiovascular disease

Research output: Contribution to journalArticle

Abstract

Calcium channel blockers are widely used agents that feature in the management of a number of cardiovascular indications, including hypertension, angina and supraventricular tachycardias. By inhibiting the movement of calcium into the cytoplasm via transmembrane calcium channels, calcium channel blockers reduce vascular and myocardial contractility, and modulate the activity of pacemaker cells. There are important differences between the different types of calcium channel blockers, and a sound understanding of their mechanism of action is required in order to promote their safe and effective use in patients. This article will briefly describe calcium channel pharmacology, the mechanism of action of calcium channel blockers and their place in the therapy of cardiovascular disease.
Original languageEnglish
Pages (from-to)64-70
Number of pages6
JournalBritish Journal of Cardiac Nursing
Volume14
Issue number2
Early online date31 Jan 2019
DOIs
Publication statusPublished - 2 Feb 2019

Fingerprint

Calcium Channel Blockers
Cardiovascular Diseases
Calcium Channels
Supraventricular Tachycardia
Blood Vessels
Cytoplasm
Pharmacology
Hypertension
Calcium
Therapeutics

Cite this

@article{493c4915788a40c5b932370a42475067,
title = "Use of calcium channel blockers in cardiovascular disease",
abstract = "Calcium channel blockers are widely used agents that feature in the management of a number of cardiovascular indications, including hypertension, angina and supraventricular tachycardias. By inhibiting the movement of calcium into the cytoplasm via transmembrane calcium channels, calcium channel blockers reduce vascular and myocardial contractility, and modulate the activity of pacemaker cells. There are important differences between the different types of calcium channel blockers, and a sound understanding of their mechanism of action is required in order to promote their safe and effective use in patients. This article will briefly describe calcium channel pharmacology, the mechanism of action of calcium channel blockers and their place in the therapy of cardiovascular disease.",
author = "Amie Bain",
year = "2019",
month = "2",
day = "2",
doi = "10.12968/bjca.2019.14.2.64",
language = "English",
volume = "14",
pages = "64--70",
journal = "British Journal of Cardiac Nursing",
issn = "1749-6403",
publisher = "Mark Allen Healthcare",
number = "2",

}

Use of calcium channel blockers in cardiovascular disease. / Bain, Amie.

In: British Journal of Cardiac Nursing, Vol. 14, No. 2, 02.02.2019, p. 64-70.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Use of calcium channel blockers in cardiovascular disease

AU - Bain, Amie

PY - 2019/2/2

Y1 - 2019/2/2

N2 - Calcium channel blockers are widely used agents that feature in the management of a number of cardiovascular indications, including hypertension, angina and supraventricular tachycardias. By inhibiting the movement of calcium into the cytoplasm via transmembrane calcium channels, calcium channel blockers reduce vascular and myocardial contractility, and modulate the activity of pacemaker cells. There are important differences between the different types of calcium channel blockers, and a sound understanding of their mechanism of action is required in order to promote their safe and effective use in patients. This article will briefly describe calcium channel pharmacology, the mechanism of action of calcium channel blockers and their place in the therapy of cardiovascular disease.

AB - Calcium channel blockers are widely used agents that feature in the management of a number of cardiovascular indications, including hypertension, angina and supraventricular tachycardias. By inhibiting the movement of calcium into the cytoplasm via transmembrane calcium channels, calcium channel blockers reduce vascular and myocardial contractility, and modulate the activity of pacemaker cells. There are important differences between the different types of calcium channel blockers, and a sound understanding of their mechanism of action is required in order to promote their safe and effective use in patients. This article will briefly describe calcium channel pharmacology, the mechanism of action of calcium channel blockers and their place in the therapy of cardiovascular disease.

U2 - 10.12968/bjca.2019.14.2.64

DO - 10.12968/bjca.2019.14.2.64

M3 - Article

VL - 14

SP - 64

EP - 70

JO - British Journal of Cardiac Nursing

JF - British Journal of Cardiac Nursing

SN - 1749-6403

IS - 2

ER -